Skip to main content

Time Plan Change of Listing Revised

Press release 2014-03-12
C-RAD is in the process of changing the listing to NASDAQ OMX Small Cap.

Press release 2014-03-12

C-RAD is in the process of changing the listing to NASDAQ OMX Small Cap.

The schedule for the change from NASDAQ OMX First North Premier to NASDAQ OMX Small Cap has been revised. C-RAD had major changes in the management team in the second half of 2013. Processes and policies have been adopted according to the requirements of the stock exchange. The new management and policies shall be effective and executed before the company will be listed at Small Cap.


Tim Thurn, CEO, C-RAD AB:

“Our objective is unchanged however it has been decided to reschedule the listing at NASDAQ OMX Small Cap. The work will progress and a new date will be communicated as soon as it is settled. The main reason for C-RAD to change to the regulated Small Cap market is to give institutional investors the opportunity to invest in C-RAD, as well as achieving international visibility for the C-RAD share.”


About C-RAD

C-RAD develops new and innovative solutions for the use in advanced radiation therapy. The company group of C-RAD offers products and solutions for patient positioning, tumor localization and radiation treatment systems. End users are radiation therapy clinics worldwide. All product development is conducted in three fully owned subsidiaries; C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB. C-RAD Imaging AB is located in Östersund while the other companies are located in Uppsala. Numbers of employees are currently 28 people. The activities in C-RAD AB originate from research and development at the Karolinska Institutet in Solna. Sales of the company’s first product, the C-RAD SentinelTM, started in 2007. Cooperation agreements have been signed with the Swedish company Elekta, the US company Varian and the Belgian company IBA. C-RAD is represented by distributors specialized in radiation therapy on major markets. C-RAD has founded three companies for direct sales, C-RAD Incorporated in the US, C-RAD GmbH in Germany and C-RAD WOFE in China. C-RAD has acquired 29 % of the laser company Cyrpa and with an option to acquire the remaining 71 %. C-RAD AB is since March 2010 listed at Nasdaq Omx First North Premier. Erik Penser Bankaktiebolag is appointed as C-RAD’s Certified Adviser.

For more information on C-RAD, please visit



For further information:

Tim Thurn, CEO C-RAD AB, Phone +46-18-666947, E-mail

Close Menu